Partner

Overview

You’re looking to create value and accelerate product development by partnering with a major pharmaceutical or biotech player. Deal structures are complex and vary wildly depending on the technological contributions of each party, degree of collaboration, financial contributions of each party, and financial participation of each party in the value created. Stakes are high and you need the full attention of experienced legal professionals who know what it takes to successfully design and negotiate a deal like yours.

Experience and Focus

At Faber, most of our attorneys have managed in-house legal departments for Big Pharma, where they launched such partnerships, then managed them throughout their life cycle. Several of us are former entrepreneurs whose business leadership resulted in successful collaborations.

A senior attorney will work closely with your scientific and business leaders to craft a strategic partnership that is “fit for purpose” — optimally designed to achieve your high priority R&D and commercial goals, while respecting your unique risk tolerance for key areas of business. We do this by considering whether each key term:

  • aligns (or misaligns) the interests of the parties,
  • maintains the necessary leverage to address and adapt flexibly to unforeseen developments and challenges, and
  • balances responsibility and risk with investment, control and potential financial reward.

Because we appreciate that these deals are about forging business relationships, we understand where they can go wrong and how to negotiate terms that will help keep them on track. Based on our operational backgrounds, we’ll help you prioritize issues and account for the details that determine real world success.

Specifically, we also have experience to use appropriately a wide variety of option based and staged deal structures. Our clients rely on us to provide sound business judgment (rooted in deep operational experience), as well as legal advice, to manage or mitigate specific risks and challenges in these structures, such as a change of control or shifts in business and scientific priorities during the full deal lifecycle.

Contact us to learn how we can help you forge a partnership that takes your company to the next level.

Related Transactions